TY - JOUR AU - Strosberg, J. PY - 2017 DA - 2017// TI - Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1607427 DO - 10.1056/NEJMoa1607427 ID - Strosberg2017 ER - TY - JOUR AU - Afshar-Oromieh, A. PY - 2015 DA - 2015// TI - The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.161299 DO - 10.2967/jnumed.115.161299 ID - Afshar-Oromieh2015 ER - TY - JOUR AU - Emmett, L. PY - 2017 DA - 2017// TI - Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy JO - J Med Radiat Sci VL - 64 UR - https://doi.org/10.1002/jmrs.227 DO - 10.1002/jmrs.227 ID - Emmett2017 ER - TY - JOUR AU - Zaknun, J. J. PY - 2013 DA - 2013// TI - The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-012-2330-6 DO - 10.1007/s00259-012-2330-6 ID - Zaknun2013 ER - TY - JOUR AU - Sandström, M. PY - 2013 DA - 2013// TI - Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.107524 DO - 10.2967/jnumed.112.107524 ID - Sandström2013 ER - TY - JOUR AU - Cremonesi, M. PY - 2006 DA - 2006// TI - Dosimetry in peptide radionuclide receptor therapy: a review JO - J Nucl Med VL - 47 ID - Cremonesi2006 ER - TY - STD TI - Baum RP, et al. Lutetium-177 PSMA radioligand therapy of metastatic castration-resistant prostate cancer: safety and efficacy. J Nucl Med. 2016; https://doi.org/10.2967/jnumed.115.168443. ID - ref7 ER - TY - JOUR AU - Kabasakal, L. PY - 2017 DA - 2017// TI - Lu-177-PSMA-617 prostate-specific membrane antigen inhibitor therapy in patients with castration-resistant prostate cancer: stability, bio-distribution and dosimetry JO - Mol Imaging Radionucl Ther VL - 26 UR - https://doi.org/10.4274/mirt.08760 DO - 10.4274/mirt.08760 ID - Kabasakal2017 ER - TY - JOUR AU - Delker, A. PY - 2016 DA - 2016// TI - Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 43 UR - https://doi.org/10.1007/s00259-015-3174-7 DO - 10.1007/s00259-015-3174-7 ID - Delker2016 ER - TY - JOUR AU - Strigari, L. PY - 2014 DA - 2014// TI - The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-014-2824-5 DO - 10.1007/s00259-014-2824-5 ID - Strigari2014 ER - TY - JOUR AU - Hindorf, C. PY - 2010 DA - 2010// TI - EANM dosimetry committee guidelines for bone marrow and whole-body dosimetry JO - Eur J Nucl Med Mol Imaging VL - 37 UR - https://doi.org/10.1007/s00259-010-1422-4 DO - 10.1007/s00259-010-1422-4 ID - Hindorf2010 ER - TY - JOUR AU - Delker, A. PY - 2015 DA - 2015// TI - The influence of early measurements onto the estimated kidney dose in [177Lu][DOTA0, Tyr3] octreotate peptide receptor radiotherapy of neuroendocrine tumors JO - Mol Imaging Biol VL - 17 UR - https://doi.org/10.1007/s11307-015-0839-3 DO - 10.1007/s11307-015-0839-3 ID - Delker2015 ER - TY - JOUR AU - Forrer, F. PY - 2009 DA - 2009// TI - Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0, Tyr3] octreotate JO - Eur J Nucl Med Mol Imaging VL - 36 UR - https://doi.org/10.1007/s00259-009-1072-6 DO - 10.1007/s00259-009-1072-6 ID - Forrer2009 ER - TY - JOUR AU - Stabin, M. G. PY - 2008 DA - 2008// TI - Uncertainties in internal dose calculations for radiopharmaceuticals JO - J Nucl Med VL - 49 UR - https://doi.org/10.2967/jnumed.107.048132 DO - 10.2967/jnumed.107.048132 ID - Stabin2008 ER - TY - JOUR AU - Dewaraja, Y. K. PY - 2012 DA - 2012// TI - MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.111.100123 DO - 10.2967/jnumed.111.100123 ID - Dewaraja2012 ER - TY - JOUR AU - Garkavij, M. PY - 2010 DA - 2010// TI - 177Lu-[DOTA0, Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: analysis of dosimetry with impact on future therapeutic strategy JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24796 DO - 10.1002/cncr.24796 ID - Garkavij2010 ER - TY - JOUR AU - He, B. PY - 2009 DA - 2009// TI - Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake JO - Med Phys VL - 36 UR - https://doi.org/10.1118/1.3063156 DO - 10.1118/1.3063156 ID - He2009 ER - TY - JOUR AU - Ljungberg, M. AU - Sjögreen-Gleisner, K. PY - 2011 DA - 2011// TI - The accuracy of absorbed dose estimates in tumours determined by quantitative SPECT: a Monte Carlo study JO - Acta Oncol VL - 50 UR - https://doi.org/10.3109/0284186X.2011.584559 DO - 10.3109/0284186X.2011.584559 ID - Ljungberg2011 ER - TY - JOUR AU - Beyer, T. PY - 2011 DA - 2011// TI - The future of hybrid imaging—part 1: hybrid imaging technologies and SPECT/CT JO - Insights Imaging VL - 2 UR - https://doi.org/10.1007/s13244-010-0063-2 DO - 10.1007/s13244-010-0063-2 ID - Beyer2011 ER - TY - JOUR AU - Ljungberg, M. PY - 2016 DA - 2016// TI - MIRD pamphlet no. 26: joint EANM/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.159012 DO - 10.2967/jnumed.115.159012 ID - Ljungberg2016 ER - TY - JOUR AU - Siegel, J. A. PY - 1999 DA - 1999// TI - MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates JO - J Nucl Med VL - 40 ID - Siegel1999 ER - TY - JOUR AU - Martinez, L. AU - Calzado, A. PY - 2016 DA - 2016// TI - Evaluation of a bilinear model for attenuation correction using CT numbers generated from a parametric method JO - Appl Radiat Isot VL - 107 UR - https://doi.org/10.1016/j.apradiso.2015.09.014 DO - 10.1016/j.apradiso.2015.09.014 ID - Martinez2016 ER - TY - JOUR AU - Hough, M. PY - 2011 DA - 2011// TI - An image-based skeletal dosimetry model for the ICRP reference adult male—internal electron sources JO - Phys Med Biol VL - 56 UR - https://doi.org/10.1088/0031-9155/56/8/001 DO - 10.1088/0031-9155/56/8/001 ID - Hough2011 ER - TY - JOUR AU - Bolch, W. E. PY - 2009 DA - 2009// TI - MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature JO - J Nucl Med VL - 50 UR - https://doi.org/10.2967/jnumed.108.056036 DO - 10.2967/jnumed.108.056036 ID - Bolch2009 ER - TY - JOUR AU - Stabin, M. G. PY - 2012 DA - 2012// TI - RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry JO - J Nucl Med VL - 53 UR - https://doi.org/10.2967/jnumed.112.106138 DO - 10.2967/jnumed.112.106138 ID - Stabin2012 ER - TY - JOUR AU - Traino, A. PY - 2007 DA - 2007// TI - Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry JO - Phys Med Biol VL - 52 UR - https://doi.org/10.1088/0031-9155/52/17/009 DO - 10.1088/0031-9155/52/17/009 ID - Traino2007 ER - TY - JOUR AU - Trover, J. K. AU - Beckett, M. L. AU - Wright, G. L. PY - 1995 DA - 1995// TI - Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids JO - Int J Cancer VL - 62 UR - https://doi.org/10.1002/ijc.2910620511 DO - 10.1002/ijc.2910620511 ID - Trover1995 ER - TY - JOUR AU - Silver, D. A. PY - 1997 DA - 1997// TI - Prostate-specific membrane antigen expression in normal and malignant human tissues JO - Clin Cancer Res VL - 3 ID - Silver1997 ER - TY - JOUR AU - Sgouros, G. PY - 1993 DA - 1993// TI - Bone marrow dosimetry for radioimmunotherapy: theoretical considerations JO - J Nucl Med VL - 34 ID - Sgouros1993 ER - TY - JOUR AU - Herrmann, K. PY - 2015 DA - 2015// TI - Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.156133 DO - 10.2967/jnumed.115.156133 ID - Herrmann2015 ER - TY - JOUR AU - Svensson, J. PY - 2016 DA - 2016// TI - A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity JO - EJNMMI Phys VL - 3 UR - https://doi.org/10.1186/s40658-016-0157-0 DO - 10.1186/s40658-016-0157-0 ID - Svensson2016 ER - TY - JOUR AU - Gustafsson, J. PY - 2015 DA - 2015// TI - Uncertainty propagation for SPECT/CT-based renal dosimetry in 177Lu peptide receptor radionuclide therapy JO - Phys Med Biol VL - 60 UR - https://doi.org/10.1088/0031-9155/60/21/8329 DO - 10.1088/0031-9155/60/21/8329 ID - Gustafsson2015 ER - TY - JOUR AU - Peterson, M. AU - Gustafsson, J. AU - Ljungberg, M. PY - 2017 DA - 2017// TI - Monte Carlo-based quantitative pinhole SPECT reconstruction using a ray-tracing back-projector JO - EJNMMI Phys VL - 4 UR - https://doi.org/10.1186/s40658-017-0198-z DO - 10.1186/s40658-017-0198-z ID - Peterson2017 ER - TY - STD TI - Bandi P, Zsoter N, Wirth A, Luetzen U, Derlin T, Papp L. New workflows and algorithms of bone scintigraphy based on SPECT-CT. In Engineering in Medicine and Biology Society (EMBC). Annual International Conference of the IEEE. 2012;5971–4. ID - ref34 ER - TY - JOUR AU - Stabin, M. AU - Flux, G. PY - 2007 DA - 2007// TI - Internal dosimetry as a tool for radiation protection of the patient in nuclear medicine JO - Biomed Imaging Interv J VL - 3 UR - https://doi.org/10.2349/biij.3.2.e28 DO - 10.2349/biij.3.2.e28 ID - Stabin2007 ER - TY - STD TI - Stabin MG, Brill AB. State of the art in nuclear medicine dose assessment. Seminars in nuclear medicine. 2008;38(5\):308–20. ID - ref36 ER - TY - JOUR AU - Bolch, W. E. PY - 1999 DA - 1999// TI - MIRD pamphlet no, 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level JO - J Nucl Med VL - 40 ID - Bolch1999 ER - TY - JOUR AU - Grimes, J. AU - Celler, A. PY - 2014 DA - 2014// TI - Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques JO - Med Phys VL - 41 UR - https://doi.org/10.1118/1.4892606 DO - 10.1118/1.4892606 ID - Grimes2014 ER - TY - JOUR AU - Hensel, J. AU - Thalmann, G. N. PY - 2016 DA - 2016// TI - Biology of bone metastases in prostate cancer JO - Urology VL - 92 UR - https://doi.org/10.1016/j.urology.2015.12.039 DO - 10.1016/j.urology.2015.12.039 ID - Hensel2016 ER -